Search Results

Bausch + Lomb Corporation today announced its ONE by ONE and Biotrue ® Eye Care Recycling programs have collected 84,343,540 units, or 510,116 pounds, of used contact lenses, eye care and lens care materials in the U.S.

Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, announced that Health Canada has approved the enVista® Envy™* full visual range intraocular lens.

Orca Bio today announced that it has completed enrollment in the pivotal Precision-T Phase 3 clinical study.

XPANCEO has announced a successful proof of concept for the world’s first augmented reality holographic lens testing system, marking an essential step towards progressing from Apple Vision Pro to the next generation of computing – XR smart contact lenses.

The Precision-Panc team at the University of Glasgow, with their Co-Sponsor, NHS Greater Glasgow & Clyde, announced the opening of the Phase II PRIMUS-006 study evaluating IMM-101, a broad-spectrum immunomodulatory agent containing heat-killed, whole cell Mycobacterium obuense, in combination with gemcitabine and pembrolizumab as first-line treatment in patients with metastatic pancreatic cancer.

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the commercial launch of its newest Light Adjustable Lens, the LAL+.

Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.